The FDA’s ANDA080301 filing for Marshall Pharma lists a single oral product: Prednisone 5 mg tablets (product number 001). The product is classified as a tablet dosage form, contains the active ingredient prednisone at a strength of 5 mg, and is marked as a discontinued marketing status. No reference drug or reference standard is indicated.
Sponsor: Marshall Pharma.
Regulatorische Updates8. Sept. 2026•1 Min. Lesezeit
Marshall Pharma Prednisone Tablet (5 mg) ANDA080301 Discontinued
FDA records indicate Marshall Pharma's oral prednisone 5 mg tablet (product 001) under application ANDA080301 is listed as discontinued.
Zusammengestellt vom PharmaCountry-Team · Quelle: FDA.gov
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen